DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Krysiak R, Okopień B.
Different effects of cabergoline and bromocriptine on metabolic and cardiovascular risk factors in patients with elevated prolactin levels.
Basic Clin Pharmacol Toxicol 2015;
116: 251-256
We do not assume any responsibility for the contents of the web pages of other providers.